BCL2 and central nervous system cancer: Moreover, we validated the expression of Bcl-2, LINC01087, and miR-384 in the glioma cells transfected with shLINC01087 or co-transfected with shLINC01087 and anti-miR-384 or pcDNA-Bcl-2 (Figure 5A).